secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001013762-23-006625
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 9.01, 3.02, 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx completes $95M acquisition of Medicx Health; appoints new President and CCO
--------------------------------------------------------------------------------

- Closed acquisition of Medicx Health for $95M in aggregate consideration (subject to adjustments).
- Management investors purchased ~$10.5M of OPRX common stock at $7.223/share as part of the deal.
- Steve Silvestro promoted to President, effective Oct 24; base salary increased to $400k.
- Theresa Greco (former Medicx President) named Chief Commercial Officer.
- Q3 2023 earnings call scheduled for Nov 6, 2023; financial results to be released prior.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/ea187250-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-006625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer